23 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... for effective treatment ... candida #mucosal #IDSA
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
IDSA Treatment Recommendations ... Maintenance Therapy Table ... Virus–Infected Individuals Table ... Transplant Recipients Table ... Meningoencephalitis #IDSA
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment ... Agents for Treatment
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Guidelines - Table ... Recommendations for the Treatment
IDSA 2017 CDiff Guidelines - Table 2. Recommendations for the Treatment of Clostridium difficile Infection in Children

#Management
IDSA 2017 CDiff ... Guidelines - Table ... Recommendations for the Treatment
Suspected catheter-related bloodstream infection - Management Algorithm
 • Temperature 37.8 C   • Rigors
Hemodynamically stable ... Resistant pathogens (S. ... Hernodynamically stable ... after treatment
June is recognized as International #Scoliosis Awareness month with the goal of public education, early detection
sideways in an "S" ... or "C" shape. ... requires active #treatment ... to successful treatment
#Cobb #Cob #angle 
June is recognized as International #Scoliosis Awareness month with the goal of public
sideways in an "S" ... or "C" shape. ... requires active #treatment ... to successful treatment
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
GrepMed Handbook S/ ... Elimination (see Table ... Stabilization Treatments ... Redistribution Treatments ... Elimination Treatments
Portopulmonary Hypertension
Presence of pulmonary arterial hypertension in a patient with portal hypertension
No other obvious causes (chronic
Cutoff > 2.8 m/s ... pressure < 15mmHg TREATMENT ... PATENT-1 study showed